immunotherapy against cancer gained popularity as a treatment modality based on the experimental model data that seemed to indicate that both specific stimulation of the immune response with antigen-bearing tumor cells and nonspecific stimulation with bacteria and other adjuvant-type compounds could enhance the existing immune response of the host and prevent recurrence or delay tumor growth .
C0003320
antigen
C0301872
immune response